Assessment of the Safety of Pembrolizumab in Patients With HIV and Advanced Cancer—A Phase 1 Study

DOI PDF 2 Citations
  • Thomas S. Uldrick
    Fred Hutchinson Cancer Research Center, Cancer Immunotherapy Trials Network, Seattle, Washington
  • Priscila H. Gonçalves
    HIV and AIDS Malignancy Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland
  • Maher Abdul-Hay
    Laura and Isaac Perlmutter Cancer Center at NYU Langone, New York, New York
  • Alisa J. Claeys
    Fred Hutchinson Cancer Research Center, Cancer Immunotherapy Trials Network, Seattle, Washington
  • Brinda Emu
    Yale University, New Haven, Connecticut
  • Marc S. Ernstoff
    Roswell Park Cancer Institute, Buffalo, New York
  • Steven P. Fling
    Fred Hutchinson Cancer Research Center, Cancer Immunotherapy Trials Network, Seattle, Washington
  • Lawrence Fong
    University of California San Francisco, San Francisco
  • Judith C. Kaiser
    Fred Hutchinson Cancer Research Center, Cancer Immunotherapy Trials Network, Seattle, Washington
  • Andreanne M. Lacroix
    Fred Hutchinson Cancer Research Center, Cancer Immunotherapy Trials Network, Seattle, Washington
  • Steve Y. Lee
    Laura and Isaac Perlmutter Cancer Center at NYU Langone, New York, New York
  • Lisa M. Lundgren
    Fred Hutchinson Cancer Research Center, Cancer Immunotherapy Trials Network, Seattle, Washington
  • Kathryn Lurain
    HIV and AIDS Malignancy Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland
  • Christopher H. Parsons
    Louisiana State University Health Science Center, New Orleans
  • Sharavi Peeramsetti
    Axio Research, Seattle, Washington
  • Ramya Ramaswami
    HIV and AIDS Malignancy Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland
  • Elad Sharon
    HIV and AIDS Malignancy Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland
  • Mario Sznol
    Yale University, New Haven, Connecticut
  • Chia-Ching (Jackie) Wang
    Zuckerberg San Francisco General Hospital, San Francisco, California
  • Robert Yarchoan
    HIV and AIDS Malignancy Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland
  • Martin A. Cheever
    Fred Hutchinson Cancer Research Center, Cancer Immunotherapy Trials Network, Seattle, Washington

Journal

  • JAMA Oncology

    JAMA Oncology 5 (9), 1332-, 2019-09-01

    American Medical Association (AMA)

Citations (2)*help

See more

Report a problem

Back to top